Manfred Hauben

Generating author description...

All published works

Action	Title	Year	Authors
+ PDF Chat	Individual Case Safety Report Replication: An Analysis of Case Reporting Transmission Networks	2022	John van Stekelenborg Vijay Kara Roman Haack Ulrich Vogel Anju Garg M Krupp Kate Gofman Brian Dreyfus Manfred Hauben Andrew Bate
+	More extreme duplication in the <scp>U.S. FDA FAERS</scp> database and a suggested check point for disproportionality analysis	2021	Manfred Hauben Chen Zou S. Bright Eric Hung
+ PDF Chat	Effects of the COVID-19 Pandemic on Spontaneous Reporting: Global and National Time-series Analyses	2020	Manfred Hauben Eric Hung
+	A visual aid for teaching the Mann–Whitney U formula	2018	Manfred Hauben
+	Time Series Disturbance Detection for Hypothesis-Free Signal Detection in Longitudinal Observational Databases	2018	Ed Whalen Manfred Hauben Andrew Bate
+ PDF Chat	A mathematical framework to quantify the masking effect associated with the confidence intervals of measures of disproportionality	2017	F. Maignen Manfred Hauben Jean-Michel Dogné
+ PDF Chat	The impact of database restriction on pharmacovigilance signal detection of selected cancer therapies	2017	Manfred Hauben Eric Hung Jennifer J. Wood Amit M Soitkar Daniel S. Reshef
+	A Pilot Study on the Feasibility of Using<i>P</i>-Plots for Signal Detection in Pharmacovigilance	2015	Manfred Hauben Chen Zou Ed Whalen Wei Wang Li Hua Zhang
+	Modelling the Time to Onset of Adverse Reactions with Parametric Survival Distributions	2010	F. Maignen Manfred Hauben Panos Tsintis
+	Systematic Investigation of Time Windows for Adverse Event Data Mining for Recently Approved Drugs	2009	Alan M. Hochberg Manfred Hauben Ronald K. Pearson Donald J. O’Hara Stephanie J. Reisinger
+	Time-to-Signal Comparison for Drug Safety Data-Mining Algorithms vs. Traditional Signaling Criteria	2009	AM Hochberg Manfred Hauben
+	The Importance of Reporting Negative Findings in Data Mining	2008	Manfred Hauben Alan M. Hochberg
+	???Extreme Duplication??? in the US FDA Adverse Events Reporting System Database	2007	Manfred Hauben Lester Reich James DeMicco Katherine Kim
+	Potential Use of Data-Mining Algorithms for the Detection of ???Surprise??? Adverse Drug Reactions	2007	Manfred Hauben Sebastian Horn Lester Reich
+	Accelerating statistical research in drug safety	2006	Warren B. Bilker Victor Gogolak David Goldsmith Manfred Hauben Guillermo A. Herrera Alan M. Hochberg S. J. Jolley Martin Kulldorff David Madigan Robert Nelson
+	Postmarketing surveillance of potentially fatal reactions to oncology drugs: potential utility of two signal-detection algorithms	2004	Manfred Hauben Lester Reich Stephanie T. Chung
+	Data mining, drug safety, and molecular pharmacology: potential for collaboration	2004	Manfred Hauben Lester Reich
+ PDF Chat	Drug‐induced pancreatitis: lessons in data mining	2004	Manfred Hauben Lester Reich
+	Application of an Empiric Bayesian Data Mining Algorithm to Reports of Pancreatitis Associated with Atypical Antipsychotics	2004	Manfred Hauben
+ PDF Chat	Trimethoprim‐induced hyperkalaemia – lessons in data mining	2004	Manfred Hauben
+	A Brief Primer on Automated Signal Detection	2003	Manfred Hauben

Common Coauthors

Coauthor	Papers Together
Lester Reich	5
Eric Hung	3
Alan M. Hochberg	3
F. Maignen	2
Ed Whalen	2
Andrew Bate	2
Kate Gofman	1
S. J. Jolley	1
Stephanie J. Reisinger	1
Chen Zou	1
Ronald K. Pearson	1
Alan Shapiro	1
Galit Shmueli	1
Warren B. Bilker	1
Brian Dreyfus	1
James DeMicco	1
Anju Garg	1
John van Stekelenborg	1
M Krupp	1
Ulrich Vogel	1
Donald J. O’Hara	1
David Goldsmith	1
Katherine Kim	1
S. Bright	1
Panos Tsintis	1
AM Hochberg	1
Victor Gogolak	1
Roman Haack	1
Wei Wang	1
Guillermo A. Herrera	1
Chen Zou	1
Robert Nelson	1
Jennifer J. Wood	1
Jean-Michel Dogné	1
David Madigan	1
Li Hua Zhang	1
Sebastian Horn	1
Amit M Soitkar	1
Vijay Kara	1
Stephanie T. Chung	1
Martin Kulldorff	1
Daniel S. Reshef	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports	2001	Stephen Evans Patrick Waller Sarah Davis	8
+	Use of Screening Algorithms and Computer Systems to Efficiently Signal Higher-Than-Expected Combinations of Drugs and Events in the US FDA??s Spontaneous Reports Database	2002	Ana Szarfman Stella G. Machado Robert T. O Neill	6
+	A Brief Primer on Automated Signal Detection	2003	Manfred Hauben	4
+	Quantitative signal detection using spontaneous ADR reporting	2009	Andrew Bate Stephen Evans	4
+ PDF Chat	Drug‐induced pancreatitis: lessons in data mining	2004	Manfred Hauben Lester Reich	4
+	Using Data Mining to Predict Safety Actions from FDA Adverse Event Reporting System Data	2007	Alan M. Hochberg Stephanie J. Reisinger Ronald K. Pearson Donald J. O’Hara Kevin Hall	3
+	A Retrospective Evaluation of a Data Mining Approach to Aid Finding New Adverse Drug Reaction Signals in the WHO International Database	2000	Marie Lindquist Malin St hl Andrew Bate I. Ralph Edwards Ronald H.B. Meyboom	3
+	Postmarketing surveillance of potentially fatal reactions to oncology drugs: potential utility of two signal-detection algorithms	2004	Manfred Hauben Lester Reich Stephanie T. Chung	2
+	???Extreme Duplication??? in the US FDA Adverse Events Reporting System Database	2007	Manfred Hauben Lester Reich James DeMicco Katherine Kim	2
+ PDF Chat	Trimethoprim‐induced hyperkalaemia – lessons in data mining	2004	Manfred Hauben	2
+	Graphical Methods in Nonparametric Statistics: A Review and Annotated Bibliography	1983	N. I. Fisher	1
+	A note on post‐marketing safety study design to characterise time‐dependent adverse events	2007	Mamoru Narukawa Akifumi Yafune	1
+	Effect of Competition Bias in Safety Signal Generation	2012	Alexandre Pariente Paul Avillach Francesco Salvo Frantz Thiessard Ghada Miremont‐Salamé Annie Fourrier‐Réglat Françoise Haramburu Bernard Bégaud Nicholas Moore	1
+	Plots of <i>P</i>-values to evaluate many tests simultaneously	1982	Tore Schweder Emil Spjøtvoll	1
+	High agreement but low kappa: II. Resolving the paradoxes	1990	Domenic V. Cicchetti Alvan R. Feinstein	1
+	Logistic Regression in Signal Detection: Another Piece Added to the Puzzle	2013	Ola Caster G. Niklas Norén David Madigan Andrew Bate	1
+	Events per person‐time (incidence rate): A misleading statistic?	2009	Helena C. Kraemer	1
+	Time-Series Modeling for Statistical Process Control	1988	Layth C. Alwan Harry V. Roberts	1
+	Letter to the Editor—Re: Almenoff et al., ‘Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post‐marketing setting’, (PDS, 2003; 12(6); 517–521)	2004	June S. Almenoff William DuMouchel L. Allen Kindman Xionghu Yang David Fram	1
+	Controversies and Contradictions in Statistical Process Control	2000	William H. Woodall	1
+ PDF Chat	Reducing the noise in signal detection of adverse drug reactions by standardizing the background: a pilot study on analyses of proportional reporting ratios-by-therapeutic area	2014	Birgitta Grundmark Lars Holmberg Hans Garmo Björn Zethelius	1
+ PDF Chat	Modelling of Infectious Diseases for Providing Signal of Epidemics: A Measles Case Study in Bangladesh	2012	Sifat Sharmin Israt Rayhan	1
+	Application of an Empiric Bayesian Data Mining Algorithm to Reports of Pancreatitis Associated with Atypical Antipsychotics	2004	Manfred Hauben	1
+ PDF Chat	Calibrated Peer Review for Interpreting Linear Regression Parameters: Results from a Graduate Course	2010	Felicity Enders Sarah M. Jenkins Verna Hoverman	1
+	Duplicate detection in adverse drug reaction surveillance	2007	G. Niklas Norén Roland Orre Andrew Bate I. Ralph Edwards	1
+ PDF Chat	Normal Approximations to the Distributions of the Wilcoxon Statistics: Accurate to What <i>N</i> ? Graphical Insights	2010	C. Bellera Marilyse Julien James A. Hanley	1
+	The detection of adverse reactions to therapeutic drugs	1982	D. J. Finney	1
+ PDF Chat	The Measurement of Observer Agreement for Categorical Data	1977	J. Richard Landis Gary G. Koch	1
+ PDF Chat	Reporting of Serious Adverse Drug Reactions of Targeted Anticancer Agents in Pivotal Phase III Clinical Trials	2010	Boštjan Šeruga Lynn Sterling Lisa Wang Ian F. Tannock	1
+	A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting Databases	2015	M Arnaud Francesco Salvo Ismaïl Ahmed Philip Robinson Nicholas Moore Bernard Bégaud Pascale Tubert‐Bitter Alexandre Pariente	1
+	Validation of Statistical Signal Detection Procedures in EudraVigilance Post-Authorization Data	2010	Yolanda Álvarez Ana Andreina Tacuri Hidalgo F. Maignen Jim Slattery	1
+	Sequence Symmetry Analysis as a Signal Detection Tool for Potential Heart Failure Adverse Events in an Administrative Claims Database	2016	Izyan A. Wahab Nicole Pratt Lisa M. Kalisch Ellett Elizabeth E. Roughead	1
+	Proof without words: Sum of Integers	1984	Ian Richards	1
+	Proof without Words: Sums of Triangular Numbers	1990	Monte J. Zerger	1
+	Bridging the Gap between Theory and Practice in Basic Statistical Process Monitoring	2016	William H. Woodall	1
+	Methods for safety signal detection in healthcare databases: a literature review	2017	M Arnaud Bernard Bégaud Nicolas H. Thurin Nicholas Moore Alexandre Pariente Francesco Salvo	1
+	Proofs Without Words and Beyond	2014	Timothy C. Doyle Lauren Kutler Robin Miller Albert W. Schueller	1
+	Time Series Disturbance Detection for Hypothesis-Free Signal Detection in Longitudinal Observational Databases	2018	Ed Whalen Manfred Hauben Andrew Bate	1
+	Tutorials in biostatistics	2004	D’Agostino R. B	1
+	WHO Declares COVID-19 a Pandemic.	2020	Domenico Cucinotta Maurizio Vanelli	1
+	Using and improving distributed data networks to generate actionable evidence: the case of real-world outcomes in the Food and Drug Administration’s Sentinel system	2020	Jeffrey S. Brown Judith C. Maro Michael Nguyen Robert Ball	1
+	Prediction of the COVID-19 Pandemic for the Top 15 Affected Countries: Advanced Autoregressive Integrated Moving Average (ARIMA) Model	2020	R. K. Singh Meenu Rani Akshaya Srikanth Bhagavathula Ranjit Sah Alfonso J. Rodríguez‐Morales Himangshu Kalita Chintan Nanda Shashi Sharma Yagya Datt Sharma Ali A. Rabaan	1
+	Erratum	2007		1
+	If nothing goes wrong, is everything all right? Interpreting zero numerators	1983	J. A. Hanley	1
+	Dissemination of Information on Potentially Fatal Adverse Drug Reactions for Cancer Drugs From 2000 to 2002: First Results From the Research on Adverse Drug Events and Reports Project	2003	Lisa A. Ladewski Steven M. Belknap Jonathan R. Nebeker Oliver Sartor E. A. Lyons Timothy C. Kuzel Martin S. Tallman Dennis W. Raisch Amy R. Auerbach Glen T. Schumock	1
+ PDF Chat	Signal Detection and Monitoring Based on Longitudinal Healthcare Data	2012	Marc Suling Iris Pigeot	1
+	Joint Estimation of Model Parameters and Outlier Effects in Time Series	1993	Chung Chen Lon‐Mu Liu	1
+	Empirical Performance of the Calibrated Self-Controlled Cohort Analysis Within Temporal Pattern Discovery: Lessons for Developing a Risk Identification and Analysis System	2013	G. Niklas Norén Tomas Bergvall Patrick Ryan Kristina Juhlin Martijn J. Schuemie David Madigan	1
+	Novel Statistical Tools for Monitoring the Safety of Marketed Drugs	2007	June S. Almenoff Edward N. Pattishall T Gibbs William DuMouchel Stephen Evans Nancy Yuen	1
+	The pair chart*	1973	Dana Quade	1